Carregant...

High Frequency Production of T Cell-Derived iPSC Clones Capable of Generating Potent Cytotoxic T Cells

Current adoptive T cell therapies conducted in an autologous setting are costly, time-consuming, and depend on the quality of the patient’s T cells, and thus it would be highly beneficial to develop an allogeneic strategy. To this aim, we have developed a method by which cytotoxic T lymphocytes (CTL...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther Methods Clin Dev
Autors principals: Nagano, Seiji, Maeda, Takuya, Ichise, Hiroshi, Kashima, Soki, Ohtaka, Manami, Nakanishi, Mahito, Kitawaki, Toshio, Kadowaki, Norimitsu, Takaori-Kondo, Akifumi, Masuda, Kyoko, Kawamoto, Hiroshi
Format: Artigo
Idioma:Inglês
Publicat: American Society of Gene & Cell Therapy 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6965501/
https://ncbi.nlm.nih.gov/pubmed/31970197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2019.12.006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!